Results 151 to 160 of about 89,726 (201)

[Urban prophylaxis against the cholera outbreak in Arica, Chile, 1886-1888]. [PDF]

Hist Cienc Saude Manguinhos
Zúñiga PC.
europepmc   +1 more source

PF-06952229, a selective TGF-β-R1 inhibitor: preclinical development and a first-in-human, phase I, dose-escalation study in advanced solid tumors. [PDF]

ESMO Open
Yap TA, Choudhury AD, Hamilton E, Rosen LS, Stratton KL, Gordon MS, Schaer D, Liu L, Zhang L, Mittapalli RK, Zhong W, Soman N, Tolcher AW.   +12 more
europepmc   +1 more source

Riesgos geológicos : terremotos

, 2008
Alonso Chaves, Francisco Manuel|||0000-0002-7079-2539, García Navarro, Encarnación|||0000-0001-6270-9101, Mantero Romero, Elena María   +2 more
openaire   +3 more sources

A First-in-Human Study of ATM Inhibitor Lartesertib as Monotherapy in Patients with Advanced Solid Tumors. [PDF]

Clin Cancer Res
Siu LL, Yap TA, Genta S, Pennock G, Hicking C, Vagge DS, Mukker JK, Locatelli G, Tolcher AW.   +8 more
europepmc   +1 more source

Telemedicine as a gateway to early-phase oncology trials: lessons from 14 000 patients and future directions for global access and equity. [PDF]

Oncologist
Torrado C, Andersen CR, Kang L, Brink AL, Adesoye T, Le H, Patterson CJ, Poullard A, Osburn JA, Tan HN, Gouda MA, Charles S, Urschel GE, Tang TY, Hong DS, Champiat S, Naing A, Tsimberidou AM, Dumbrava EE, Piha-Paul SA, Rodon J, Yap TA, Pohlmann PR, Meric-Bernstam F, Fu S.   +24 more
europepmc   +1 more source

Testing new anticancer drugs before curative locoregional therapies: MDICT 2024 recommendations. [PDF]

ESMO Open
Methodology for the Development of Innovative Cancer Therapies Taskforce. Electronic address: lseymour@ctg.queensu.ca.
europepmc   +1 more source

Modulating Treatment Outcomes of Patients with Solid Tumors in Immunotherapy Trials: A Drug Interaction Analysis from a Phase I Unit. [PDF]

Cancer Res Commun
Braganca Xavier C, Andersen CR, Lim J, Slade JH, Bean SA, Kang L, Le H, Tsimberidou AM, Naing A, Hong DS, Dumbrava EE, Rodon Ahnert J, Pohlmann PR, Piha-Paul SA, Champiat S, Yap TA, Tang TY, Meric-Bernstam F, Fu S.   +18 more
europepmc   +1 more source

Dynamic time warping network analysis of posttraumatic stress symptoms in Japanese first responders. [PDF]

Eur J Psychotraumatol
van der Does FHS, Kitano M, Nagamine M, Saito T, van der Wee NJA, Chiba T, Edo N, Vermetten E, Giltay EJ.   +8 more
europepmc   +1 more source

Phase 1 first-in-human dose-escalation study of IMSA101, a novel cyclic di-nucleotide STING agonist, for patients with advanced solid tumor malignancies. [PDF]

J Immunother Cancer
Jacoby J, Mahalingam D, Alistar A, Garmey E, Kazmi S, Mooneyham T, Sun L, Yap TA, Vu P, Moser J.   +9 more
europepmc   +1 more source